Tenet Reports Results for the First Quarter Ended March 31, 2019
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/22/2026
- Nasdaq notches record-high close, AI optimism reignites and Treasury yields retreat
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
- Oil price dips to $100 on hopes of US-Iran diplomacy, partial recovery in Saudi exports
- Paramount, Warner Bros jump on report of settlement progress in merger fight
- Investors may be underpricing how far rate hikes could go, Deutsche says
- Pennsylvania measles cases near 800 as outbreak grows
- A timeline of Trump administration moves to weaken endangered species protections
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
- Nasdaq notches record-high close, AI optimism reignites and Treasury yields retreat
- SpaceX and Tesla’s AI linkup is getting deeper. Here’s what Morgan Stanley sees
Tenet Healthcare (THC) Tops Q1 EPS by 25c, Revenues Beat; Offers Q2 & FY19 Revenue Mid-Point Guidance Above Consensus, Provides 2Q/FY19 EPS Views
April 29, 2019 4:18 PM EDTTenet Healthcare (NYSE: THC) reported Q1 EPS of $0.54, $0.25 better than the analyst estimate of $0.29. Revenue for the quarter came in at $4.55 billion versus the consensus estimate of $4.51 billion.
Tenet reported a net loss from continuing operations attributable to Tenet common shareholders of $27 million or $0.26 per diluted share in the first quarter of 2019 due in part to a $47 million pre-tax loss from the extinguishment of debt or $0.45 per diluted share.Adjusted diluted earnings per share from continuing operations were $0.54 in the first quarter of 2019, above the high end of the Companys... More